Crossmark

Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets

Crossref DOI link: https://doi.org/10.1016/j.xcrm.2022.100894

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bradford, Hannah F.

Haljasmägi, Liis

Menon, Madhvi

McDonnell, Thomas C.R.

Särekannu, Karita

Vanker, Martti

Peterson, Pärt

Wincup, Chris

Abida, Rym

Gonzalez, Raquel Fernandez

Bondet, Vincent

Duffy, Darragh

Isenberg, David A.

Kisand, Kai

Mauri, Claudia https://orcid.org/0000-0001-9761-2625
Funding

Funding for this research was provided by:

Agence Nationale de la Recherche (CE17001002)

Eesti Teadusagentuur (PRG1117)

Eesti Teadusagentuur (PRG377)

European Regional Development Fund (2014-2020.4.01.15-0012)

Versus Arthritis (21140)

Versus Arthritis (21786)

Academy of Medical Sciences (SBF006\1165)

Biotechnology and Biological Sciences Research Council (BB/P504725/1)
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2022-12-15
More Information

This article is maintained by: Elsevier

Article Title: Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets

Journal Title: Cell Reports Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.xcrm.2022.100894

Content Type: article

Copyright: Crown Copyright © 2022